BridgeBio Pharma, Inc. Common Stock (BBIO) stock analysis and AI prediction
The company facts of BridgeBio Pharma, Inc. Common Stock, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About BridgeBio Pharma, Inc. Common Stock
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. Its key drug is Attruby (acoramidis), an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $15.2 billion
- Size
- Large cap
- Employees
- 839
- Headquarters
- PALO ALTO, CA
- Listed since
- June 27, 2019
- Website
- bridgebio.com
More Healthcare stocks
Other large cap stocks
Keep going
BBIO questions
What is the AI prediction for BBIO stock?
Each market day our model rates BridgeBio Pharma, Inc. Common Stock (BBIO) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the BBIO prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for BBIO?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see BBIO options?
The BBIO options page opens its calls and puts, with price, volume, implied volatility and the Greeks.